Fluoxetine and extrapyramidal symptoms. Two case reports
Daric, C.; Dollfus, S.; Mihout, B.; Omnient, Y.; Petit, M.
L'Encephale 19(1): 61-62
1993
ISSN/ISBN: 0013-7006 PMID: 8275894 Document Number: 416153
Document emailed within 1 workday
Related Documents
Glick, I.D.; Jacobs, M.; Lieberman, J.; Simpson, G.; Schooler, N.R. 1989: Prediction of short term outcome in schizophrenia: depressive symptoms, negative symptoms, and extrapyramidal signs. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 344-347Husag, L.; Wieser, H.G.; Probst, C. 1975: Extrapyramidal symptoms in meningiomas Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 116(2): 257-279
Berlin, C.S. 1996: Fluoxetine withdrawal symptoms Journal of Clinical Psychiatry 57(2): 93-94
Saha, P.; Verma, A.K.; Saluja, S.; Sharma, S.K. 1990: Extrapyramidal symptoms in varicella zoster infection Journal of the Association of Physicians of India 38(4): 312-313
Zinchenko, A.P.; Sharaia, N.N.; Savchenko, A.V. 1977: Atypical symptoms and their pathogenesis in extrapyramidal tumors Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 77(6): 801-806
Kane, J.M.; Safferman, A.Z.; Pollack, S.; Johns, C.; Szymanski, S.; Kronig, M.; Lieberman, J.A. 1994: Clozapine, negative symptoms, and extrapyramidal side effects Journal of Clinical Psychiatry 55(Suppl): 74-77
Consoloni, E.; Rossi, R.; Ioppoli, C.; Cartei, M.A.; Fonte, F. 1980: Hereditary degenerative spinocerebellar syndrome with extrapyramidal symptoms Rivista di Neurologia 50(4): 221-230
Bettin, S.; Kämpfer, I.; Seese, A.; Schäfer, A.; Reuter, M.; Lössner, J.; Dietrich, J.; Wagner, A.; Knapp, W.H. 1997: Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms Nuklearmedizin. Nuclear Medicine 36(5): 167-172
Sanderson, D.R. 1996: Drug interaction between risperidone and phenytoin resulting in extrapyramidal symptoms Journal of Clinical Psychiatry 57(4): 177
Jorgensen, H.; Vogt, H. 1977: Familial, idiopathic hypoparathyroidism with intracerebral calcifications and extrapyramidal symptoms Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 97(15): 771-774
Kikuchi, A. 2009: An 8-year-old boy presenting with progressive extrapyramidal symptoms during total parenteral nutrition No to Hattatsu 41(5): 325-326
Ettlin, T.; Kischka, U.; Kaeser, H.E. 1989: Cognitive and psychological disorders following whiplash injury: 2 case reports concerning the controversy between the organic versus the psychogenic etiology of symptoms Schweizerische Rundschau für Medizin Praxis 78(36): 967-969
Zamami, M.; Igarashi, T. 1987: Analysis and evaluation of case reports by students and a discussion on focal points in the preparation of the reports--comments on the reports presented at the past 14 issues Kurinikaru Sutadi 8(3): 296-302
Wu, C-Ying.; Chou, L-Tai.; Chen, H-Ping.; Chang, C-Sen.; Wong, P-Guan.; Chen, G-Hum. 2003: Effect of fluoxetine on symptoms and gastric dysrhythmia in patients with functional dyspepsia Hepato-Gastroenterology 50(49): 278-283
Žáková, D.; Trudáková, L.; Farhat, F.S.; Kalixová, Ž.; Náhlík, I.; Rejholec, J.; Lejčková, R.; Bareš, S.; Hankeová-Bonhome, Z.; Reicho, R.; Paličková, J.; Ullrychova, J. 2015: Different outcome in two case reports of births showing symptoms of amniotic fluid embolism in the years 2002 and 2012 in the district hospital of Decin Ceska Gynekologie 80(4): 302-308
Garcin, R.; Raverdy, P.; Delthil, S.; Man, H.X.; Chimenes, H. 1961: On a heredo-familial disease combining cataract, optic atrophy, extrapyramidal symptoms and certain defects of Friedreich's disease. (Its nosological position in relation to the Behr's syndrome, the Marinesco-Sjogren syndrome and Friedreich's disease with ocular symptoms Revue Neurologique (Paris) 104: 373-379
Inada, T. 1996: Recent research trends in diagnosis, treatment, and prevention of drug-induced extrapyramidal symptoms seen in psychiatric patients Nihon Shinkei Seishin Yakurigaku Zasshi 16(5): 181-185
Nakazono, Y.; Abe, H.; Murakami, H.; Koyabu, N.; Isaka, Y.; Nemoto, Y.; Murata, S.; Tsutsumi, Y.; Ohtani, H.; Sawada, Y. 2005: Association between neuroleptic drug-induced extrapyramidal symptoms and dopamine D2-receptor polymorphisms in Japanese schizophrenic patients International Journal of Clinical Pharmacology and Therapeutics 43(4): 163-171
Regenthal, R.; Kunstler, U.; Hesse, S.; Sabri, O.; Preiss, R. 2005: D2 dopamine receptor occupancy, risperidone plasma level and extrapyramidal motor symptoms in previously drug-free schizophrenic patients International Journal of Clinical Pharmacology and Therapeutics 43(8): 370-378
Dominguez, R.A.; Kumar, A.M.; Cua, W. 1996: Lack of change in fluoxetine and norfluoxetine kinetics when switching from fluoxetine to paroxetine Journal of Clinical Psychopharmacology 16(4): 320-323